Bell Pharmaceuticals Inc

Ear Relief Drops Earwax Removal Drops Earwax Removal Drops Kit

Catalog

Ear Relief

Documents

Allergens
(not added) A
COA template
(not added) COA
Country of origin
(not added) COO
Item questionnaire
(not added) IQ
Nutrition
(not added) N
Product specification
(not added) PS
SDS (Safety Data Sheet)
(not added) SDS
Suitability requirements
(not added) SR

Earwax

Documents

Allergens
(not added) A
COA template
(not added) COA
Country of origin
(not added) COO
Item questionnaire
(not added) IQ
Nutrition
(not added) N
Product specification
(not added) PS
SDS (Safety Data Sheet)
(not added) SDS
Suitability requirements
(not added) SR

Earwax Removal Aid Earwax Removal Drops

Topco Ear Drops

Documents

Allergens
(visible)
Click to download A
Product specification
(visible)
Click to download PS
COA template
(not added) COA
Country of origin
(not added) COO
Item questionnaire
(not added) IQ
Nutrition
(not added) N
SDS (Safety Data Sheet)
(not added) SDS
Suitability requirements
(not added) SR

Topco Ear Wax Removal Drops

Documents

Allergens
(visible)
Click to download A
Product specification
(visible)
Click to download PS
COA template
(not added) COA
Country of origin
(not added) COO
Item questionnaire
(not added) IQ
Nutrition
(not added) N
SDS (Safety Data Sheet)
(not added) SDS
Suitability requirements
(not added) SR

Topco Ear Wax Removal Kit

Documents

Allergens
(visible)
Click to download A
Product specification
(visible)
Click to download PS
COA template
(not added) COA
Country of origin
(not added) COO
Item questionnaire
(not added) IQ
Nutrition
(not added) N
SDS (Safety Data Sheet)
(not added) SDS
Suitability requirements
(not added) SR

Locations

Location name	Address
Bell Pharmaceuticals Inc	200 West Beaver Street PO Bx 128 Belle Plaine, MN 56011 USA

Documents

Type	Location	File name	Effective	Expiration
3rd Party Audit Report	Bell Pharmaceuticals Inc	2024 Bell Pharmaceuticals Inc. 997975 Final Assessment Results.pdf	3/19/2024	11/12/2024
Quarterly Adverse Event Report	Bell Pharmaceuticals Inc	Adverse Event Quarterly Report November 2024.xlsx	11/14/2024	2/12/2025
3rd Party Audit Certificate	Bell Pharmaceuticals Inc	final- US-F6A_605300_Non-FoodQMS_Bell Pharmaceuticals Inc._BellePlaineMN_TR_JL.pdf	3/29/2018	3/29/2019
Contact Information	Bell Pharmaceuticals Inc	Supplier Contact Information 2024.docx	4/16/2024	4/16/2025
Recall/Emergency/Contact List	Bell Pharmaceuticals Inc	Topco Emergency Contact Info.docx	11/22/2022	11/22/2023